• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估计一项在群组随机试验中的干预效果的受限平均生存时间。

Restricted mean survival time to estimate an intervention effect in a cluster randomized trial.

机构信息

INSERM, SPHERE, U1246, Tours University, Nantes University, Tours, France.

INSERM, SPHERE, U1246, Nantes University, Tours University, Nantes, France.

出版信息

Stat Methods Med Res. 2023 Oct;32(10):2016-2032. doi: 10.1177/09622802231192960. Epub 2023 Aug 9.

DOI:10.1177/09622802231192960
PMID:37559486
Abstract

For time-to-event outcomes, the difference in restricted mean survival time is a measure of the intervention effect, an alternative to the hazard ratio, corresponding to the expected survival duration gain due to the intervention up to a predefined time *. We extended two existing approaches of restricted mean survival time estimation for independent data to clustered data in the framework of cluster randomized trials: one based on the direct integration of Kaplan-Meier curves and the other based on pseudo-values regression. Then, we conducted a simulation study to assess and compare the statistical performance of the proposed methods, varying the number and size of clusters, the degree of clustering, and the magnitude of the intervention effect under proportional and non-proportional hazards assumption. We found that the extended methods well estimated the variance and controlled the type I error if there was a sufficient number of clusters (≥ 50) under both proportional and non-proportional hazards assumption. For cluster randomized trials with a limited number of clusters (< 50), a permutation test for pseudo-values regression was implemented and corrected the type I error. We also provided a procedure to estimate permutation-based confidence intervals which produced adequate coverage. All the extended methods performed similarly, but the pseudo-values regression offered the possibility to adjust for covariates. Finally, we illustrated each considered method with a cluster randomized trial evaluating the effectiveness of an asthma-control education program.

摘要

对于生存时间结局,受限平均生存时间的差异是干预效果的一种衡量指标,可替代风险比,对应于由于干预导致的预期生存时间延长,最长至预定时间*。我们将两种现有的独立数据受限平均生存时间估计方法扩展到群组随机试验框架中的群组数据中:一种基于直接整合 Kaplan-Meier 曲线,另一种基于伪值回归。然后,我们进行了一项模拟研究,以评估和比较所提出方法的统计性能,方法是在比例和非比例风险假设下,改变群组的数量和大小、群组的聚集程度以及干预效果的大小。我们发现,如果在两种比例和非比例风险假设下有足够数量的群组(≥50),则扩展方法可以很好地估计方差并控制 I 型错误。对于群组数量有限(<50)的群组随机试验,我们实施了伪值回归的置换检验,并校正了 I 型错误。我们还提供了一种程序来估计基于置换的置信区间,该置信区间具有适当的覆盖范围。所有扩展方法的性能相似,但伪值回归提供了调整协变量的可能性。最后,我们通过一项评估哮喘控制教育计划效果的群组随机试验说明了每种考虑的方法。

相似文献

1
Restricted mean survival time to estimate an intervention effect in a cluster randomized trial.估计一项在群组随机试验中的干预效果的受限平均生存时间。
Stat Methods Med Res. 2023 Oct;32(10):2016-2032. doi: 10.1177/09622802231192960. Epub 2023 Aug 9.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.在可能预期治疗效果存在非比例风险的临床试验设计中增强对数秩检验。
BMC Med Res Methodol. 2016 Feb 11;16:16. doi: 10.1186/s12874-016-0110-x.
4
Design of non-inferiority randomized trials using the difference in restricted mean survival times.基于受限平均生存时间差值的非劣效性随机临床试验设计。
Clin Trials. 2018 Oct;15(5):499-508. doi: 10.1177/1740774518792259. Epub 2018 Aug 3.
5
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.个体患者数据荟萃分析中估计受限平均生存时间差异的方法的偏倚和精度。
BMC Med Res Methodol. 2016 Mar 29;16:37. doi: 10.1186/s12874-016-0137-z.
6
Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.适用于具有连续结局的部分嵌套随机对照试验的适当统计方法:一项模拟研究。
BMC Med Res Methodol. 2018 Oct 11;18(1):105. doi: 10.1186/s12874-018-0559-x.
7
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.不同人群水平汇总指标在时间事件结局随机试验中的比较,重点关注非劣效性试验。
Clin Trials. 2023 Dec;20(6):594-602. doi: 10.1177/17407745231181907. Epub 2023 Jun 20.
8
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.利用两个生存函数的综合差异来量化治疗对比,以用于设计、监测和分析比较性临床研究。
Clin Trials. 2012 Oct;9(5):570-7. doi: 10.1177/1740774512455464. Epub 2012 Aug 22.
9
Adjusting for covariates in analysis based on restricted mean survival times.基于限制平均生存时间的分析中调整协变量。
Pharm Stat. 2022 Jan;21(1):38-54. doi: 10.1002/pst.2151. Epub 2021 Jul 6.
10
Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice.随机对照试验的设计和分析中是否考虑了非恒定率和非比例治疗效果?对当前实践的回顾。
BMC Med Res Methodol. 2019 May 16;19(1):103. doi: 10.1186/s12874-019-0749-1.